JONATHAN MULLIS: Open Payments
NPI 1396945135 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 9 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $41 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 1 | $54 |
| Dexcom, Inc. | 2 | $45 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| BETA BIONICS, INC. | 1 | $28 |
| Novo Nordisk Inc | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
Products named: TWIIST, Dexcom G6 Transmitter, TZIELD, iLet Bionic Pancreas, Sogroya, TRIPTODUR, Omnipod, GVOKE HYPOPEN.
Industry payments across GA — which companies pay providers there.
